echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Heavy! The eighth batch of national procurement reporting documents involved 41 varieties and 181 product specifications

    Heavy! The eighth batch of national procurement reporting documents involved 41 varieties and 181 product specifications

    • Last Update: 2023-02-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The eighth batch of national procurement is here!

    On January 10, a notice issued by the National Organization Drug Joint Procurement Office on Submitting the Eighth Batch of Procurement Data Related to the Scope of Centralized Procurement of Drugs by State Organizations was circulated in the industry
    .

    According to online documents, each province began to organize medical institutions in their regions to carry out the eighth batch of national procurement drug procurement demand filling work, a total of 41 varieties, 181 product specifications included in the report catalog
    .
    The author extracted the key contents based on the online transmission documents, and used the pharmacointelligence database to sort out
    the competitive landscape of related varieties.

    ▍ Institutional scope

    Public medical institutions and military medical institutions in all provinces should participate; Other socially-run medical institutions voluntarily participate
    in accordance with the relevant provisions of the province where they are located.

    ▍ Filling method

    This data filling is carried out by online direct reporting, and the historical procurement volume data in 2021 is imported by each province for medical institutions to refer to when filling in the relevant drug procurement demand, and medical institutions fill in the procurement demand according to the reporting specifications
    .

    The medical insurance departments of each province organize relevant medical institutions within their jurisdictions to complete the filling in work through the "National Organization Drug Centralized Procurement Comprehensive Service Platform" (hereinafter referred to as the "system", website: http://blxt.
    smpaa.
    cn) within the specified time, and the drug list can be queried and downloaded
    in the system.
    The provincial management user account, medical institution account and password follow the seventh batch of national centralized procurement, please refer to the operation manual or operation video
    in the system for specific operation methods.

    ▍ Timeline

    Before 24:00 on January 12 (Thursday), the medical insurance departments of each province will maintain and manage user accounts and medical institution accounts, and relevant users will complete the reporting operation test
    .

    On January 13 (Friday), the official launch of the volume report, and the medical insurance departments of various provinces introduced the historical procurement volume data of 2021 for the reference of medical institutions
    .
    Medical institutions must fill in the relevant drug procurement requirements as required and submit data
    by 24:00 on February 8 (Wednesday).

    Before 17:00 on February 21 (Tuesday), all provinces are requested to complete the review of relevant drug procurement demand, summarize, export and print, affix the official seal of the Provincial Medical Insurance Bureau, and submit the electronic file and scanned copy to the joint procurement office
    by the system.
    For the list and format of drugs, please refer to the "Provincial (Regional, Municipal, Corps) Relevant Drug Procurement Demand Filling Form"
    .

    Appendix 1: Fill in the report of relevant drug procurement demand

           

           

           

           

           

           

           

           

           

           

           

    Appendix 2: The current competitive pattern of the eighth batch of centralized procurement varieties

           

    Data sources: NMPA, pharmacointelligence data

    PS: The data is manually statistically collated, if there is a missing data, please understand, but also please correct in the comment area, thank you!

    If this article violates your rights, please contact us
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.